SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/07/20 Guided Therapeutics Inc 10-Q 3/31/20 62:4.4M Blueprint/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 490K 2: EX-31 Certification Pursuant to Rule 13A-14(A)/15D-14(A) HTML 26K Certifications Section 302 of the Sarbanes-Oxly Act of 2002 3: EX-32 Certificate Pursuant to Section 18 U.S.C. Pursuant HTML 20K to Section 906 of the Sarbanes-Oxley Act of 2002 10: R1 Document and Entity Information HTML 50K 11: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 160K 12: R3 Condensed Consolidated Balance Sheets HTML 60K (Parenthetical) 13: R4 Condensed Consolidated Statements of Operations HTML 118K (Unaudited) 14: R5 Consolidated Statements of Stockholders' Deficit HTML 65K 15: R6 Condensed Consolidated Statements of Cash Flows HTML 103K (Unaudited) 16: R7 1. Organization, Background, and Basis of HTML 32K Presentation 17: R8 2. Significant Accounting Policies HTML 71K 18: R9 3. Fair Value of Financial Instruments HTML 44K 19: R10 4. Stockholders' Deficit HTML 81K 20: R11 5. Stock Options HTML 21K 21: R12 6. Litigation and Claims HTML 21K 22: R13 7. Commitments and Contingencies HTML 35K 23: R14 8. Notes Payable HTML 49K 24: R15 9. Short-Term Convertible Debt HTML 37K 25: R16 10. Convertible Debt HTML 59K 26: R17 11. Long Term Debt HTML 42K 27: R18 12. Income (Loss) Per Common Share HTML 31K 28: R19 13. Subsequent Events HTML 28K 29: R20 2. Significant Accounting Policies (Policies) HTML 133K 30: R21 2. Significant Accounting Policies (Tables) HTML 46K 31: R22 3. Fair Value of Financial Instruments (Tables) HTML 42K 32: R23 4. Stockholders' Deficit (Tables) HTML 56K 33: R24 7. Commitments and Contingencies (Tables) HTML 22K 34: R25 8. Notes Payable (Tables) HTML 32K 35: R26 9. Short-Term Convertible Debt (Tables) HTML 23K 36: R27 10. Convertible Debt (Tables) HTML 33K 37: R28 11. Long Term Debt (Tables) HTML 35K 38: R29 12. Income (Loss) Per Common Share (Tables) HTML 29K 39: R30 1. Organization, Background, and Basis of HTML 52K Presentation (Details Narrative) 40: R31 2. Significant Accounting Policies (Details) HTML 30K 41: R32 2. Significant Accounting Policies (Details 1) HTML 32K 42: R33 2. Significant Accounting Policies (Details 2) HTML 39K 43: R34 2. Significant Accounting Policies (Details 3) HTML 33K 44: R35 2. Significant Accounting Policies (Details HTML 32K Narrative) 45: R36 3. Fair Value of Financial Instruments (Details) HTML 42K 46: R37 3. Fair Value of Financial Instruments (Details 1) HTML 35K 47: R38 4. Stockholders' Deficit (Details) HTML 26K 48: R39 4. Stockholders' Deficit (Details 1) HTML 65K 49: R40 4. Stockholders' Deficit (Details 2) HTML 29K 50: R41 4. Stockholders' Deficit (Details 3) HTML 51K 51: R42 4. Stockholders' Deficit (Details Narrative) HTML 27K 52: R43 7. Commitments and Contingencies (Details) HTML 28K 53: R44 8. Notes Payable (Details) HTML 35K 54: R45 8. Notes Payable (Details 1) HTML 37K 55: R46 9. Short-Term Convertible Debt (Details) HTML 31K 56: R47 10. Convertible Debt in Default (Details) HTML 35K 57: R48 11. Long Term Debt (Details) HTML 50K 58: R49 11. Long Term Debt (Details 1) HTML 38K 59: R50 12. Income (Loss) Per Common Share (Details) HTML 56K 61: XML IDEA XML File -- Filing Summary XML 111K 60: EXCEL IDEA Workbook of Financial Reports XLSX 94K 4: EX-101.INS XBRL Instance -- gthp-20200331 XML 1.39M 6: EX-101.CAL XBRL Calculations -- gthp-20200331_cal XML 165K 7: EX-101.DEF XBRL Definitions -- gthp-20200331_def XML 380K 8: EX-101.LAB XBRL Labels -- gthp-20200331_lab XML 675K 9: EX-101.PRE XBRL Presentations -- gthp-20200331_pre XML 586K 5: EX-101.SCH XBRL Schema -- gthp-20200331 XSD 141K 62: ZIP XBRL Zipped Folder -- 0001654954-20-007405-xbrl Zip 117K
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 7/7/20 | |||
For Period end: | 3/31/20 | 8-K, NT 10-Q | ||
12/31/19 | 10-K | |||
9/30/18 | 10-Q | |||
9/4/18 | ||||
List all Filings |